Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-000820
Filing Date
2025-05-09
Accepted
2025-05-09 15:16:14
Documents
41
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q welsis_10q.htm   iXBRL 10-Q 385386
2 CERTIFICATION welsis_ex311.htm EX-31.1 10038
3 CERTIFICATION welsis_ex321.htm EX-32.1 3989
  Complete submission text file 0001640334-25-000820.txt   1769862

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA welsis-20250331.xsd EX-101.SCH 19667
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE welsis-20250331_lab.xml EX-101.LAB 114008
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE welsis-20250331_cal.xml EX-101.CAL 23025
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE welsis-20250331_pre.xml EX-101.PRE 88098
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE welsis-20250331_def.xml EX-101.DEF 24695
44 EXTRACTED XBRL INSTANCE DOCUMENT welsis_10q_htm.xml XML 140012
Mailing Address 701 E CATHEDRAL RD STE 45 PMB 405 PHILADELPHIA PA 19128
Business Address 701 E CATHEDRAL RD STE 45 PMB 405 PHILADELPHIA PA 19128 215-552-8991
Welsis Corp. (Filer) CIK: 0001887912 (see all company filings)

EIN.: 000000000 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-56527 | Film No.: 25929923
SIC: 8000 Services-Health Services
(CF Office: 08 Industrial Applications and Services)